Samsung Biologics Co.,Ltd. (207940.KS) KSC

1,651,000.00

-29000(-1.73%)

Updated at December 05 12:44PM

Currency In KRW

Valuation

Market Cap67.54T
Enterprise Value68.64T
P/E Ratio59.58
PEG Ratio119.22
Price/Sales Ratio15.23
Price/Book Ratio6.6
Enterprise/Revenue15.37
Enterprise/EBITDA30.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.26
Operating Margin0.32

Management Effectiveness

Return On Assets0.07
Return On Equity0.12

Income Statement

Revenue4.55T
Revenue/Share108,697.16
Gross Profit2.29T
EBITDA2.02T
Net Income1.08T
Diluted EPS23,402.85

Balance Sheet

Total Cash1.64T
Total Cash/Share35,529.4
Total Debt1.42T
Total Debt/Equity0.12
Current Ratio1.57
Book Value Per Share250,649.4

Price History

52-Week Change12.01
52-Week High1.94M
52-Week Low1.4M
Moving Average 50 Days1.73M
Moving Average 200 Days1.64M

Statistics

Average Volume53,882
Shares Outstanding46.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor650391:1000000
Last Split DateOctober 30, 2025